Your browser doesn't support javascript.
loading
Ranolazine Prevents Levosimendan-Induced Atrial Fibrillation.
Ellermann, Christian; Kohnke, Anja; Dechering, Dirk G; Kochhäuser, Simon; Reinke, Florian; Fehr, Michael; Eckardt, Lars; Frommeyer, Gerrit.
Afiliação
  • Ellermann C; Department of Cardiology II (Electrophysiology), University Hospital Münster, Münster, Germany.
  • Kohnke A; Department of Cardiology II (Electrophysiology), University Hospital Münster, Münster, Germany.
  • Dechering DG; Department of Cardiology II (Electrophysiology), University Hospital Münster, Münster, Germany.
  • Kochhäuser S; Department of Cardiology II (Electrophysiology), University Hospital Münster, Münster, Germany.
  • Reinke F; Department of Cardiology II (Electrophysiology), University Hospital Münster, Münster, Germany.
  • Fehr M; Clinic of Exotic Pets, Reptiles, Exotic and Feral Birds, University of Hanover, Hanover, Germany.
  • Eckardt L; Department of Cardiology II (Electrophysiology), University Hospital Münster, Münster, Germany.
  • Frommeyer G; Department of Cardiology II (Electrophysiology), University Hospital Münster, Münster, Germany.
Pharmacology ; 102(3-4): 138-141, 2018.
Article em En | MEDLINE | ID: mdl-29982246
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridazinas / Fibrilação Atrial / Ranolazina / Hidrazonas / Antiarrítmicos Tipo de estudo: Guideline Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridazinas / Fibrilação Atrial / Ranolazina / Hidrazonas / Antiarrítmicos Tipo de estudo: Guideline Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article